{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.137A>G",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "A",
            "alt": "G",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000345.3:c.89G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000345.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dementia with Lewy bodies",
    "MONDO": "MONDO:0005835"
  },
  "Experiment Method": [
    {
      "Assay Method": "Liposome Binding Assay",
      "Material used": {
        "Material Source": "Artificial material",
        "Material Name": "Liposomes",
        "Description": "Brain phosphatidylcholine (PC) and cholesterol were purchased from Avanti Polar Lipids (Birmingham, AL). Brain phosphatidylserine (PS) was obtained from Sigma-Aldrich."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutation E46K increased the binding of a-synuclein to type A liposomes by 88% and to type B liposomes by 56%."
        },
        {
          "Variant": "NM_000345.3:c.89G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Mutation A30P reduced the binding of a-synuclein to type A liposomes by 95% and to type B liposomes by 53%."
        },
        {
          "Variant": "NM_000345.3:c.158C>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Mutation A53T led to a non-significant 9-12% reduction in the binding of a-synuclein to both liposome types."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "The results are presented as means ± S.E.M. of the measurements obtained from three independent protein preparations, each run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "wild-type GST-a-synuclein taken as 100%."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific binding due to GST bound to beads."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding of wild-type GST-a-synuclein taken as 100%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding significantly different from wild-type GST-a-synuclein.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Filament Assembly Assay",
      "Material used": {
        "Material Source": "Artificial material",
        "Material Name": "Recombinant human a-synucleins",
        "Description": "Recombinant a-synuclein"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K a-synuclein showed a faster rate of assembly and a 2.5-fold greater total assembly than the wild-type protein at 98 h (Fig. 3)."
        },
        {
          "Variant": "NM_000345.3:c.89G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "The rate of assembly of the A30P mutant was slower than for wild-type a-synuclein, but the amount of assembly was similar to that of the E46K and A53T mutants at 98 h (Fig. 3)."
        },
        {
          "Variant": "NM_000345.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutant behaved in a similar way to E46K a-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "The results are presented as normalized fluorescence (with the value for wild-type a-synuclein at 98 h taken as 100) and expressed as the means ± S.E.M. of the measurements obtained from three independent protein preparations."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ThT fluorescence at 98 h for wild-type a-synuclein",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ThT fluorescence at 98 h significantly different for mutants.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}